Craig A. Portell, MD¹, Opeyemi Jegede^2*, N. Nora Bennani, MD³, Seema Naik, MD⁴, Christopher M. Reynolds, MD, BA⁵, Priyank P. Patel, MD^6*, Michael J. Robertson, MD⁷ and Brad S. Kahl, MD⁸

¹Division of Hematology and Oncology, Department of Medicine, University of Virginia Medical Center, Charlottesville, VA
²CIMAC-CIDC Network, Department of Data Science, Boston, MA
³Mayo Clinic, Rochester, MN
⁴Penn State University College of Medicine, Hershey, PA
⁵St. Joseph Mercy Hospital, IHA Hematology-Oncology Consultants, Ypsilanti, MI
⁶Carle Cancer Center, Urbana, IL
⁷Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN
⁸Washington University School of Medicine in St. Louis, Saint Louis, MO

Michael L. Wang, MD¹, Sarit Assouline, MD², Manali Kamdar, MD^3*, Nilanjan Ghosh, MD, PhD⁴, Seema Naik, MD^5*, Shazia K. Nakhoda, MD^6*, Julio C. Chavez, MD^7*, Ting Jia, MD^8*, Song Pham, MSc^9*, Ling-Yuh Huw, PhD^10*, Jing Jing, PhD^10*, Wahib Ead, PharmD^10*, Iris To, PharmD^10*, Connie Lee Batlevi, MD^10*, Michael C. Wei, MD, PhD¹⁰ and Elizabeth Lihua Elizabeth Budde, MD, PhD¹¹

¹University of Texas MD Anderson Cancer Center, Houston, TX
²Jewish General Hospital, McGill University, Montreal, QC, Canada
³Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO
⁴Atrium Health Levine Cancer Institute, Charlotte, NC
⁵Penn State Cancer Institute, Hershey, PA
⁶Fox Chase Cancer Center, Philadelphia, PA
⁷Moffitt Cancer Center, Tampa, FL
⁸Roche (China) Holding Ltd, Shanghai, China
⁹Hoffmann-La Roche Ltd, Mississauga, ON, Canada
¹⁰Genentech, Inc., South San Francisco, CA
¹¹City of Hope National Medical Center, Duarte, CA

Eliza A Hawkes, MD¹, Sze Ting Lee, MBBS, FRACP, FAANMS, PhD^2*, Leonid Churilov, PhD^3*, Tasman Armytage, MBBS^4*, Georgina Hodges, FRACP, MBBS, FRCPA^5*, Chan Yoon Cheah, MBBS⁶, Joel Wight^7*, Nicole Wong Doo, MBBS, MD, FRACP, FRCPA⁸, Matthew Ku, MBBS, PhD⁹, Stephen S. Opat, MBBS, FRACP, FRCPA¹⁰, Tara Cochrane, MBBS, FRCPA, FRACP¹¹, Greg Hapgood, M.D., Ph.D^12*, Hui-Peng Lee, MD^13*, Rishu Agarwal^14*, Wendi Lin^15*, Minu Koshy^16*, Mannu Walia, PhD^17*, Liudmyla Olenko^18*, Paul Sung-Hao Yeh, MBBS, PhD^19*, Bianca Devitt, MBBS, FRACP, PhD^20* and Allison A Barraclough, BSc, FRACP, FRCPA, MBBS²¹

¹Dept of Haematology & Medical Oncology and Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, Australia
²Dept Molecular Imaging and Therapeutics, Austin Health, Heidelberg, VIC, Australia
³University of Melbourne, Parkville, AUS
⁴Gosford Hospital, Gosford, Australia
⁵Clinical Haematology, Barwon Health, Geelong, Australia
⁶The University of Western Australia, Perth, Australia
⁷Dept Haematology, Townsville Hospital, Townsville, AUS
⁸Department of Haematology, Concord Hospital, University of Sydney, New South Wales, Australia, Concord, NSW, AUS
⁹St Vincent's Hospital, Melbourne, AUS
¹⁰School of Clinical Sciences, Monash University, Melbourne, VIC, Australia
¹¹Department of Haematology, Gold Coast University Hospital, Southport, Australia
¹²Princess Alexandra Hospital, Brisbane, AUS
¹³Flinders Hospital, Adelaide, Australia
¹⁴Pathology, Austin Health, MOUNT WAVERLEY, AUS
¹⁵Dept Pathology, Austin Health, Heidelberg, AUS
¹⁶Dept Pathology, Austin Health, Heidelberg, Australia
¹⁷Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
¹⁸University of Melbourne, Parkville, Australia
¹⁹Monash Health/Monash University, Clayton, VIC, AUS
²⁰Medical Oncology, Eastern Health Clinical School, Box Hill, Australia
²¹Haematology Department Fiona Stanley Hospital Murdoch, wa, Australia

Huilai Zhang, MD^1*, Liping Su^2*, Lihong Liu^3*, Ou Bai, MD/PhD^4*, Zheng Song^1*, Zhiqiang Zhao^2*, Cuiying He^3*, Qiang Guo^5*, Xianhuo Wang, MD^1*, Wei Li^1*, Lihua Qiu^1*, Lanfang Li^1*, Shiyong Zhou^1*, Yue Fei^1*, Xiaohui Wang^1* and Bin Meng^1*

¹Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
²Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China
³The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
⁴The First Hospital of Jilin University, Changchun, Jilin, China
⁵The First Bethune Hospital of Jilin University, Changchun, China

Carlo Visco^1*, Valentina Tabanelli^2*, Maria Vittoria Sacchi^3*, Andrea Evangelista^4*, Isacco Ferrarini^5*, Maria Chiara Tisi^6*, Anna Merli^7*, Stefano Fiori^8*, Vittorio Ruggero Zilioli^9*, Alessandro Re, MD^10*, Claudia Castellino, MD^11*, Francesco Piazza, MD^12*, Paolo Corradini, MD¹³, Stefan Hohaus^14*, Gerardo Musuraca, MD, PhD^15*, Francesca Gaia Rossi^16*, Benedetta Puccini, MD^17*, Federica Cavallo^18*, Filippo Ballerini, MD^19*, Roberta Sciarra^20*, Alice Di Rocco^21*, Annalisa Arcari, MD^22*, Carola Boccomini, MD^23*, Francesco Merli, MD^24*, Guido Gini, MD²⁵, Monica Tani^26*, Riccardo Bruna^27*, Vincenzo Pavone, MD^28*, Andrés José María Ferreri, MD²⁹, Armando Santoro, MD^30*, Caterina Patti, MD^31*, Giacomo Loseto, MD^32*, Marco Ladetto³³, Michele Merli^34*, Michele Spina, MD^35*, Pier Luigi Zinzani, MD, PhD³⁶, Piero Maria Stefani^37*, Sara Usai, MD^38*, Stefano Pileri² and Monica Balzarotti, MD^39*

¹Department of Engineering for Innovation Medicine/Section of Hematology, University of Verona, Verona, Italy
²Haematopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy
³Fondazione Italiana Linfomi, Onlus, Alessandria, Italy
⁴Unit of Cancer Epidemiology, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy
⁵Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy
⁶ULSS 8 Berica - Ospedale S. Bortolo - Ematologia, Vicenza, ITA
⁷Ospedale degli Infermi di Rimini - U.O. di Ematologia, Rimini, ITA
⁸Istituto Europeo di Oncologia (IEO) - Haematopathology Unit, Milano, Italy
⁹Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
¹⁰UC Hematology, ASST Spedali Civili di Brescia, Brescia BS, Italy
¹¹SC Ematolgoa, Ospedale Santa Croce e Carle, Cuneo, Italy
¹²University of Padua, Padova, Italy
¹³University of Milan and Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
¹⁴Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
¹⁵IRCCS Istituto Romagnolo per lo studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
¹⁶Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, ITA
¹⁷Unitа Ematologia, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
¹⁸Division of Hematology and Stem Cell Transplant Unit, AOU Città della Salute e della Scienza, Torino, Italy
¹⁹IRCCS Ospedale Policlinico San Martino, Genoa, Italy
²⁰Fondazione IRCCS Policlinico San Matteo, Pavia, ITA
²¹Policlinico Umberto I, Roma, ITA
²²UO Ematologia, Ospedale Guglielmo da Saliceto, Piacenza, Italy
²³SC Ematologia, AOU Città della Salute e della Scienza, Torino, Italy
²⁴SC Ematologia, IRCCS - Arcispedale Santa Maria Nuova, REGGIO EMILIA, ITA
²⁵Hematology Unit, AUO Ospedali Riuniti, Università Politecnica delle Marche, Ancona, ITA
²⁶Ematologia, Ospedale Santa Maria delle Croci, Ravenna, Italy
²⁷Universit� Del Piemonte Orientale Amedeo Avogadro, Novara, ITA
²⁸Hematology Unit, Azienda C. Panico, Tricase, Italy
²⁹Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
³⁰IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Rozzano, Milan, Italy
³¹Division of Hematology 1, Azienda Ospedali Riunita Villa Sofia-Cervello, Palermo, Italy
³²IRCCS Istituto Tumori “Giovanni Paolo II”, Hematology Unit, Bari, Italy
³³Department of Translational Medicine, Università del Piemonte Orientale SCDU Ematologia SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
³⁴Ospedale Di Circolo E Fondazione Macchi Varese, Varese, ITA
³⁵Division of Medical Oncology, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
³⁶Hematology, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
³⁷Ospedale Ca Foncello - S.C di Ematologia, Treviso, ITA
³⁸Ospedale Oncologico Armando Businco, Cagliari, ITA
³⁹Humanitas Research Hospital IRCCS, Rozzano Milano, Italy

Anita Kumar, MD¹, Jacob Soumerai, MD², Jeremy S. Abramson, MD³, Jeffrey A. Barnes, MD, PhD⁴, Philip Caron, MD⁵, Maria Chabowska, BSc^6*, Mary Devlin^7*, Ahmet Dogan, MD, PhD⁸, Lorenzo Falchi, MD⁹, Rayna N. Garcia^7*, Clare Grieve, MPH^6*, Emma Haskell^7*, Julie E. Haydu, MD PhD^3*, Patrick Connor Johnson, MD¹⁰, Ashlee Joseph^11*, Hailey E. Kelly^7*, Alyssa Labarre^6*, Emerald D Littlejohn, MPH^12*, Jennifer Kimberly Lue^6*, Joanna Mi^6*, Rosalba Martignetti^3*, Grace McCambridge^7*, Alison Moskowitz, MD⁶, Colette Owens, MD⁵, Sean F. Plummer^7*, Madeline G. Puccio^7*, Gilles Salles, MD, PhD⁹, Venkatraman Seshan, PhD^6*, Natalie Slupe^6* and Andrew D. Zelenetz, MD, PhD⁵

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
²Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA
³Massachusetts General Hospital Cancer Center, Boston, MA
⁴Massachusetts General Hosp. Cancer Ctr., Boston, MA
⁵Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Memorial Sloan Kettering Cancer Center, New York, NY
⁷Massachusetts General Hospital, Boston, MA
⁸Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
¹⁰Cancer Center, Massachusetts General Hospital, Boston, MA
¹¹Memorial Sloan Kettering Cancer Center, New York
¹²Dana-Farber Cancer Institute, Boston, MA